Zervos E E, Goode S E, Rosemurgy A S
Department of Surgery, College of Medicine, University of South Florida, Tampa 33606, USA.
J Surg Res. 1998 Jan;74(1):71-5. doi: 10.1006/jsre.1997.5194.
Effective hepatic blood flow is thought to play a critical role in outcome following portal decompressive procedures. We have shown previously that hepatic arterialization occurs soon after shunting, preserving nutrient flow, but the remote effects of shunting are unknown. The purpose of this study was to determine the effect of small-diameter prosthetic H-graft portacaval shunt (HGPCS) on effective hepatic blood flow (EHF) and portal pressures 1 year from shunt placement.
Patients undergoing 8-mm HGPCS had effective hepatic blood flow determined using low-dose galactose clearance preoperatively, postoperatively, and at 1 year postshunt. Portal blood flow, pressures, and portal vein/inferior vena cava pressure gradients were determined intraoperatively before and after shunt placement and at 1 year.
Twenty patients undergoing shunting had flows measured. All patients had significant reductions in portal vein/inferior vena cava pressure gradients while effective hepatic flow was maintained immediately postoperatively. At 1 year following shunting, effective hepatic blood flow was significantly lower than both pre- and postoperative rates of flow while portal pressures and gradients were significantly increased. Albumin, cholesterol, and PT were improved at 1 year while total bilirubin was slightly worse. Nineteen of 20 patients are still alive with average follow-up of 26 +/- 10.3 months. Four patients were encephalopathic preop, 5 postop, and none chronically.
Recollateralization of varices and progression of cirrhosis may account for the observed reductions in EHF at 1 year. Regardless of the cause, diminution of EHF at 1 year is well compensated as demonstrated by minimal encephalopathy and ascites, improved hepatic function reflected in blood chemistry profiles, and good survival.
有效肝血流量被认为在门静脉减压术后的预后中起关键作用。我们之前已经表明,分流术后很快会发生肝动脉化,从而维持营养物质流动,但分流的远期影响尚不清楚。本研究的目的是确定小直径人工血管H型门腔分流术(HGPCS)对分流术后1年有效肝血流量(EHF)和门静脉压力的影响。
接受8毫米HGPCS的患者在术前、术后及分流术后1年通过低剂量半乳糖清除率测定有效肝血流量。术中在分流前后及1年时测定门静脉血流量、压力以及门静脉/下腔静脉压力梯度。
对20例行分流术的患者进行了血流测量。所有患者的门静脉/下腔静脉压力梯度均显著降低,而术后即刻有效肝血流量得以维持。分流术后1年,有效肝血流量显著低于术前和术后的血流速率,而门静脉压力和梯度显著升高。1年时白蛋白、胆固醇和凝血酶原时间有所改善,而总胆红素略有恶化。20例患者中有19例仍存活,平均随访时间为26±10.3个月。4例患者术前有肝性脑病,5例术后出现,无慢性肝性脑病患者。
静脉曲张的再通和肝硬化的进展可能是导致观察到的1年时EHF降低的原因。无论原因如何,1年时EHF的降低得到了很好的代偿,表现为肝性脑病和腹水极少、血液生化指标反映的肝功能改善以及良好的生存率。